Skip to content

Pain and Functional Improvement in Cases of Frozen Shoulder by Nerve block Or Shoulder Joint Injection

Efficacy between Suprascapular Nerve Block SSNB Hydro dilatation HD and Their Combination in the Management of Periarthritis Shoulder Grade III - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097257
Enrollment
165
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Supra scapular nerve block (SSNB): 2ml of 2% lignocaine and 4ml of 0.2% Ropivacaine , 40mg triamcinolone acetonide injection. follow up at 2,6 and 12 weeks. total duration 18 months C

Sponsors

NRS Medical College Kolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosis case of periarthritis shoulder Frozen shoulder stage III not managed by conservatively like Therapeutic exercise, Analgesic . 2. Adult below 60 years both gender 3.Patients with pain and stiffness at least 9 months duration. 4. Patients who will give consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Recent shoulder surgery/trauma within 4weeks , local infection 2. Uncontrolled Diabetes mellitus , hypothyroidism not adequately managed. 3. Pregnancy, Lactation 4. Pain cause due to disorder of Cervical spine, elbow, wrist or hand, CRPS 5. Neurological disease such as stroke, peripheral neuropathy that affected the shoulder 6. Patients has history of drug allergy to lignocaine, bupivacaine/ropivacaine, 7. Severe systemic disease like infection, malignancy, Coagulopathy, 8. Severe degenerative (Rheumatoid arthritis, osteoarthritis) 9. Patients has received nerve block or hydrodilatation preceding 4 week.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale VASTimepoint: baseline 2 weeks 6 weeks 12 weeks

Secondary

MeasureTime frame
Shoulder Pain and Disability Index SPADI ScaleTimepoint: baseline 2 weeks 6 weeks 12 weeks;Pittsburgh Sleep Quality Index PQSI Timepoint: 2 weeks 6 weeks 12 weeks

Countries

India

Contacts

Public ContactSaumen Kumar De

NRS Medical College

drsaumen16@yahoo.com9433124596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026